A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial

A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of test food on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035337

Enrollment

Registered

2019-01-18

Start date

2019-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Test participants intake one package of test food dissolved in 180ml water 15 min before consuming high fat meal. Test participants intake one package of control food dissolved in 180ml water 15 min b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Males and females aged 20 to 64 years old when informed consent and body mass index (BMI) is included between 18.5 to less than 30 (2)Individuals whose fasting serum triglyceride level at the time of screening is 150mg/dL or less (3) Individuals who do not drink large amount of alcohol habitually (4) Individuals who are judged that not suffering from a disease. (5)Individuals giving written informed consent

Exclusion criteria

Exclusion criteria: (1)Individuals who use oral medication affecting lipid metabolism (2)Individuals who constantly use supplements and/or functional foods, including food for specified health use and/or food with function claims, affecting lipid metabolism (3)Individuals who are suffered from or under treatment of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder (4)Individuals who have a chronic disease and use medicines continuously (5)Individuals who are diagnosed as severe anemia and not suitable for frequent collection of blood (6)Individuals who had an onset diarrhea within one week from the date of screening, and who is prone to diarrhea always (7)Individuals who are diagnosed as familial hyperlipidemia (8)Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (9)Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Design outcomes

Primary

Measure	Time frame
Time course of serum triglyceride level and AUC (area under the curve)(0-6hrs)	—

Secondary

Measure	Time frame
Time course of serum RLP-cholesterol level and AUC (area under the curve)(0-6hrs)	—

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026